Cyberonics, Inc. [clinicaltrials_resource:7bfbdcfb26294f5f82b9f2f98f44eb6d]
Bryan Olin [clinicaltrials_resource:139cda42e8223eb5701937f44d81e48e]Abraham Kroon, MD, PhD [clinicaltrials_resource:1526800ff7e961797416facd992a3b32]Mark Bunker, PharmD [clinicaltrials_resource:1568942fa6a1e7ce0c0f00ab9dbd493f]Jason Begnaud [clinicaltrials_resource:27828093e5dcb40177f9ee19c7cb0298]Mark Bunker, PharmD [clinicaltrials_resource:3cd4fd093d884a49e87d78649beab513]Mark Bunker, Ph.D [clinicaltrials_resource:47652a1093fc179f11287ed2d2fe822b]Mark Bunker, PharmD [clinicaltrials_resource:629af6cc2c495d2ab81d93ea9cc658ea]Mark Bunker, Ph.D [clinicaltrials_resource:6a3fa868cc8c0ef6ed10ca0853c18183]Mark Bunker, PharmD [clinicaltrials_resource:6ae8b99e7ebcad4405a90cf26fd70d44]Mark Bunker, PharmD [clinicaltrials_resource:73db22a4c968b2c975f064ee1bd6b37b]Carol C Base, RN, MS [clinicaltrials_resource:7e14c0829fae2b54698e661a7a524031]Investigator [clinicaltrials_resource:ab1efa1695cac41c6fba2b5397c3a477]Imad Libbus, PhD [clinicaltrials_resource:c95785303abe2353adcb97b83a1db8f6]Mark Bunker, PharmD [clinicaltrials_resource:cd56dc6bf38705315be406e9495efd3d]Mark Bunker, Ph.D [clinicaltrials_resource:e5911c59e5eced5736d0aec88b38aa9e]Mark Bunker, PharmD [clinicaltrials_resource:faee43613b642f8963f04c453e476600]Mark Bunker, Ph.D [clinicaltrials_resource:fd196fda557aa72fdf619657d572709b]
affiliation [clinicaltrials_vocabulary:affiliation]
collaborator [clinicaltrials_vocabulary:collaborator]
Effectiveness Study Comparing Treatment With Drug(s) or Adjunctive VNS Therapy for Pharmacoresistant Partial Seizures [clinicaltrials:NCT00215215]clinicaltrials:NCT00305565Treatment-Resistant Depression Registry [clinicaltrials:NCT00320372]clinicaltrials:NCT00522418Pivotal Trial (D02) of Vagus Nerve Stimulation (VNS) for Treatment-Resistant Depression (TRD) [clinicaltrials:NCT00533832]clinicaltrials:NCT01118455Heart Rate Changes in Subjects With Epilepsy [clinicaltrials:NCT01202669]Heart Rate Changes During Normal Activity, Exercise, and Sleep in Normal Healthy Subjects With and Without Epilepsy [clinicaltrials:NCT01202682]Heart Rate Changes During Normal Activity, Exercise, and Seizures in Subjects With Epilepsy [clinicaltrials:NCT01214707]Heartbeat Sensitivity Calibration Using the ECG Accessory [clinicaltrials:NCT01268007]PuLsE 2-Observational Long-Term Effectiveness Follow-Up Study of PuLsE 1 [clinicaltrials:NCT01281280]Vagus Nerve Stimulation Clinical Outcomes Measured Prospectively in Patients Stimulated [clinicaltrials:NCT01281293]Seizure Detection and Automatic Magnet Mode Performance Study [clinicaltrials:NCT01325623]Physiological and Biomechanical Data Collection Study in Epilepsy Subjects [clinicaltrials:NCT01485016]ECG Vector Determination [clinicaltrials:NCT01486056]3-Dimensional Accelerometer Sub-Study [clinicaltrials:NCT01612689]Study to Evaluate a New Device Designed to Collect Heart Activity and Body Movement Data [clinicaltrials:NCT01626599]clinicaltrials:NCT01823887clinicaltrials:NCT01846741Vagus Nerve Stimulation Titration Protocol to Improve Tolerance and Accelerate Adaptation [clinicaltrials:NCT02385526]
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
Effectiveness Study Comparing Treatment With Drug(s) or Adjunctive VNS Therapy for Pharmacoresistant Partial Seizures [clinicaltrials:NCT00215215]clinicaltrials:NCT00305565Treatment-Resistant Depression Registry [clinicaltrials:NCT00320372]clinicaltrials:NCT00522418Pivotal Trial (D02) of Vagus Nerve Stimulation (VNS) for Treatment-Resistant Depression (TRD) [clinicaltrials:NCT00533832]clinicaltrials:NCT01118455Heart Rate Changes in Subjects With Epilepsy [clinicaltrials:NCT01202669]Heart Rate Changes During Normal Activity, Exercise, and Sleep in Normal Healthy Subjects With and Without Epilepsy [clinicaltrials:NCT01202682]Heart Rate Changes During Normal Activity, Exercise, and Seizures in Subjects With Epilepsy [clinicaltrials:NCT01214707]Heartbeat Sensitivity Calibration Using the ECG Accessory [clinicaltrials:NCT01268007]PuLsE 2-Observational Long-Term Effectiveness Follow-Up Study of PuLsE 1 [clinicaltrials:NCT01281280]Vagus Nerve Stimulation Clinical Outcomes Measured Prospectively in Patients Stimulated [clinicaltrials:NCT01281293]Seizure Detection and Automatic Magnet Mode Performance Study [clinicaltrials:NCT01325623]Physiological and Biomechanical Data Collection Study in Epilepsy Subjects [clinicaltrials:NCT01485016]ECG Vector Determination [clinicaltrials:NCT01486056]3-Dimensional Accelerometer Sub-Study [clinicaltrials:NCT01612689]Study to Evaluate a New Device Designed to Collect Heart Activity and Body Movement Data [clinicaltrials:NCT01626599]clinicaltrials:NCT01823887clinicaltrials:NCT01846741Vagus Nerve Stimulation Titration Protocol to Improve Tolerance and Accelerate Adaptation [clinicaltrials:NCT02385526]
source [clinicaltrials_vocabulary:source]
Cyberonics, Inc. [clinicaltrials_resource:7bfbdcfb26294f5f82b9f2f98f44eb6d]
Bio2RDF identifier
7bfbdcfb26294f5f82b9f2f98f44eb6d
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:7bfbdcfb26294f5f82b9f2f98f44eb6d
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:7bfbdcfb26294f5f82b9f2f98f44eb6d
title
Cyberonics, Inc.
@en
type
label
Cyberonics, Inc. [clinicaltrials_resource:7bfbdcfb26294f5f82b9f2f98f44eb6d]
@en